News & Updates

Erenumab effective for migraine regardless of aura status

28 Jan 2022 by

In a post hoc analysis, use of the anti-CGRP* receptor monoclonal antibody erenumab led to reduced migraine frequency and AMSM** days in individuals with migraine with and without a history of aura.

Erenumab effective for migraine regardless of aura status

28 Jan 2022

Pneumonia in infancy spells bigger risk of subsequent chronic respiratory disorders

28 Jan 2022

The occurrence of community-acquired pneumonia (CAP) in infancy, especially closer to preschool age, confers a heightened risk of developing subsequent chronic respiratory disorders, a study has found.

Pneumonia in infancy spells bigger risk of subsequent chronic respiratory disorders

28 Jan 2022

Severe food insecurity ups diabetes risk

28 Jan 2022

In poor urban settings, severe food insecurity aggravates the risk of diabetes, a recent study from Angola has found.

Severe food insecurity ups diabetes risk

28 Jan 2022

FVIII/PC predicts complication risk in ACLD, but not coagulation potential

27 Jan 2022

In patients with advanced chronic liver disease (ACLD), ratio of procoagulant factor VIII to anticoagulant protein C (FVIII/PC) is significantly prognostic of decompensation, death, and acute-on-chronic liver failure (ACLF), a new study has found. However, FVIII/PC is not related to thrombosis and does not reflect coagulation.

FVIII/PC predicts complication risk in ACLD, but not coagulation potential

27 Jan 2022

Low FODMAP diet promising in management of persistent symptoms in coeliac disease

27 Jan 2022

For treated patients with coeliac disease (CD) who are experiencing persistent symptoms, a short-term diet with moderately low fermentable oligo-, di-, monosaccharides and polyols (FODMAP) helps reduce gastrointestinal symptoms and improve CD-specific health, as suggested in a study.

Low FODMAP diet promising in management of persistent symptoms in coeliac disease

27 Jan 2022

Dronedarone better than sotalol in post-AF ablation setting

27 Jan 2022 by

Treatment with dronedarone following atrial fibrillation (AF) ablation appears to lead to a reduced risk of cardiovascular hospitalization as well as lower rates of combined proarrhythmia when compared with sotalol, as shown in a recent study.

Dronedarone better than sotalol in post-AF ablation setting

27 Jan 2022

Motivators, barriers to better heart health practices in Singapore

27 Jan 2022 by

Among adults with potentially modifiable behavioural risk factors for cardiovascular diseases, the patterns of motivators and barriers to such modifications vary widely, often depending on age and social status, according to a recent Singapore study.